|
Doug Watson. Mr. Watson has served as our director since 2005. He is Chairman, President and interim Chief Executive Officer of Ondine Biopharma Corp., a company that develops therapies for treating periodontal disease utilizing photosensitive compounds and lasers and that is listed on the Toronto Stock Exchange. From 1996 to 2003, he was employed by Gensci Regeneration Sciences, Inc., a company that provides surgeons with biologically based products for bone repair and regeneration, and that was listed on the Toronto Stock Exchange until its sale in 2003, serving as President and Chief Executive Officer from 2001 to 2003. He has a background in product marketing, distribution and corporate finance. | 